Edwards Lifesciences Corporation today announced the company's SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

Put your wellbeing front and centre with this curated list of specialist clinics and private healthcare providers ...

CT can accurately quantify LA and LV volumes. Using electrocardiographic gating, the cardiac cycle is specifically analyzed to identify end-diastolic frames corresponding to the closure of the mitral ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter ...